Prostatic Intraepithelial Neoplasia Human Prostate Total RNA, Donor 2399 (CAT#: DBFF-0624-HY5486)

Datasheet

Overview

Prostatic intraepithelial neoplasia is a non-invasive precancerous lesion in the prostatic epithelium. It is often considered an early stage of prostate cancer, but does not break through the upper cortex and spread to surrounding tissues. Prostatic Intraepithelial Neoplasia Human Prostate Total RNA, Donor 2399 is extracted from prostate tissue of a single prostatic intraepithelial neoplasia human donor using a classical guanidine isothiocyanate-phenol: chloroform extraction method. RNA goes through rigorous quality control procedures to ensure the highest quality possible.

Product Summary

Quantity:

* For Research Use Only. Not For Clinical Use.

Donor Information

Gender

Male

Age At Sampling

61 yrs

Medical Diagnosis

Adenocarcinoma of prostate

Product Description

Species

Human

Tissue Name

Prostate

Sample Diagnosis Category

Prostatic Intraepithelial Neoplasia

28S/18S Ratio

1.73

Size

5 µg

Shipping

Dry ice

Storage

Stored at -80°C without repeated freeze and thaws

Applications

Northern blotting, ribonuclease protection assay, polymerase chain reaction analysis, rapid amplification of cDNA end analysis, cDNA synthesis, RNA differential display, microRNA studies, and RNA library construction.

Product Properties

Normal Ratio

Lesional Ratio

100%

Tumor Ratio

Hypocellular/Acellular Tumor Stroma Ratio

Hypercellular Tumor Stroma Ratio

Necrosis Ratio

H&E Staining Pathological Verification

Non-neoplastic lesional component consists of 10% hyperplastic prostatic glands, 50% high grade prostatic intraepithelial neoplasia; Normal component consists of 40% fibromuscular stroma

Technical Specifications

Quality Control

Tested by spectrophotometer and denatured agarose gel electrophoresis

For Research Use Only | Not For Clinical Use